// App-Quantinova.ai

THU0568 (2018) : Biosimilar use in patients with juvenile idiopathic arthritis in a real-world setting in the united kingdom

Researchers

Presenter

  • D. De Cock

Principal Investigators

  • L. Kearsley-Fleet

  • R. Davies

  • E. Baildam

  • M. Beresford

  • H. Foster

  • T. Southwood

  • W. Thomson

  • K. Hyrich

Medical Centers

  • Arthritis Research UK Centre for Epidemiology, the University of Manchester

  • Clinical Academic Department of Paediatric Rheumatology, Alder Hey Children's NHS FoundationTrust, Liverpool

  • Newcastle University, Newcastle Upon Tyne, UK

  • School of Immunity and Infection, Birmingham University, Birmingham

  • Arthritis Research UK Centre for Genetics and Genomics, Manchester, United Kingdom

  • Manchester Academic Health Science Centre, Central Manchester NHS Foundation Trust, Manchester, UK

Locations

  • United States

  • United Kingdom

  • South Africa

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Etanercept biosimilar

  • Infliximab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved